Literature DB >> 23948281

The expression of histone deacetylase 4 is associated with prednisone poor-response in childhood acute lymphoblastic leukemia.

Bernd Gruhn1, Thomas Naumann, Dorothee Gruner, Mario Walther, Susan Wittig, Sabine Becker, James F Beck, Jürgen Sonnemann.   

Abstract

This study aimed at the identification of histone deacetylase (HDAC) isoforms relevant for childhood acute lymphoblastic leukemia (ALL). Expression of HDAC1-11 was determined in 93 primary ALL and eight healthy donor samples. HDAC1, HDAC2 and HDAC8 showed significantly higher expressions in ALL samples. Correlation analysis of HDAC expression with clinicopathological parameters revealed that high HDAC1, HDAC2, HDAC4 and HDAC11 levels were significantly associated with unfavorable prognostic factors. Particularly, high HDAC4 expression was associated with high initial leukocyte count, T cell ALL and prednisone poor-response. siRNA-mediated inhibition of HDAC4 sensitized a T-ALL cell line to etoposide-induced cell death. In conclusion, our data point to HDAC4 as drug target in childhood ALL, especially in prednisone poor-responders.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Childhood ALL; Gene expression; HDAC; Prednisone response; Vorinostat

Mesh:

Substances:

Year:  2013        PMID: 23948281     DOI: 10.1016/j.leukres.2013.07.016

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  24 in total

1.  Loss of TBL1XR1 disrupts glucocorticoid receptor recruitment to chromatin and results in glucocorticoid resistance in a B-lymphoblastic leukemia model.

Authors:  Courtney L Jones; Teena Bhatla; Roy Blum; Jinhua Wang; Steven W Paugh; Xin Wen; Wallace Bourgeois; Danielle S Bitterman; Elizabeth A Raetz; Debra J Morrison; David T Teachey; William E Evans; Michael J Garabedian; William L Carroll
Journal:  J Biol Chem       Date:  2014-07-25       Impact factor: 5.157

Review 2.  Histone deacetylases and mechanisms of regulation of gene expression.

Authors:  Hong Ping Chen; Yu Tina Zhao; Ting C Zhao
Journal:  Crit Rev Oncog       Date:  2015

Review 3.  Histone deacetylase inhibitors and epigenetic regulation in lymphoid malignancies.

Authors:  Diana Markozashvili; Vincent Ribrag; Yegor S Vassetzky
Journal:  Invest New Drugs       Date:  2015-09-30       Impact factor: 3.850

Review 4.  Advances in biology of acute lymphoblastic leukemia (ALL) and therapeutic implications.

Authors:  Mahsa Mohseni; Hasan Uludag; Joseph M Brandwein
Journal:  Am J Blood Res       Date:  2018-12-10

Review 5.  HDACs and HDAC Inhibitors in Cancer Development and Therapy.

Authors:  Yixuan Li; Edward Seto
Journal:  Cold Spring Harb Perspect Med       Date:  2016-10-03       Impact factor: 6.915

6.  Strong Correlation between the Expression Levels of HDAC4 and SIRT6 in Hematological Malignancies of the Adults.

Authors:  Zsuzsanna Gaál; Éva Oláh; László Rejtő; Ferenc Erdődi; László Csernoch
Journal:  Pathol Oncol Res       Date:  2016-10-20       Impact factor: 3.201

Review 7.  The biology of relapsed acute lymphoblastic leukemia: opportunities for therapeutic interventions.

Authors:  Teena Bhatla; Courtney L Jones; Julia A Meyer; Nicholas A Vitanza; Elizabeth A Raetz; William L Carroll
Journal:  J Pediatr Hematol Oncol       Date:  2014-08       Impact factor: 1.289

Review 8.  Beyond the coding genome: non-coding mutations and cancer.

Authors:  Kaivalya Walavalkar; Dimple Notani
Journal:  Front Biosci (Landmark Ed)       Date:  2020-06-01

Review 9.  Histone acetyltransferases and histone deacetylases in B- and T-cell development, physiology and malignancy.

Authors:  Leila Haery; Ryan C Thompson; Thomas D Gilmore
Journal:  Genes Cancer       Date:  2015-05

10.  Association of MDR1 G2677T polymorphism and leukemia risk: evidence from a meta-analysis.

Authors:  Yulan Yan; Hongjie Liang; Li Xie; Yu He; Meng Li; Ruolin Li; Shan Li; Xue Qin
Journal:  Tumour Biol       Date:  2013-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.